UTMB researchers identify proteins that block immune response to COVID-19

October 16, 20204 min

Researchers from The University of Texas Medical Branch at Galveston have discovered SARS-CoV-2 proteins that suppress the body’s immune response, thereby enabling infection and transmission of the disease.

The findings are paramount to understanding the biology of COVID-19 and to developing new vaccines against the disease.

“The outcome of any infection is determined by pathogen amplification and immune response inside our body. In the case of COVID-19 patients, it is important to understand how SARS-CoV-2 replicates and how our immune system develops protective immunity, the two sides of the equation upon viral infection,” said Pei-Yong Shi, professor at Department of Biochemistry & Molecular Biology at UTMB. “In this study, we performed an unbiased screen of viral proteins from SARS-CoV-2 for their abilities to suppress interferon response. Such information is critical to understand how the virus shuts off host immune system to facilitate viral amplification in COVID-19 patients.”

“Interferon is the first line of defense when we encounter viral infection. We found that multiple viral proteins could suppress interferon production and signaling through different mechanisms,” said Hongjie Xia, the UTMB research scientist, senior co-author of the study.  “Our study has provided knowledge for new approaches for live-attenuated vaccine development. For example, we can now engineer mutant viruses that cannot suppress host immune response. Such mutant viruses could be used to prime our immune system as vaccine candidates. Since these mutant viruses could not fight against immune system, they would be rapidly eliminated by our immune response without causing disease.”

“The study also showed that the same proteins from different coronaviruses, such as SARS-CoV-2, MARS-CoV, and SARS-CoV-2, have different levels of potency in inhibiting interferon response. Such differences may partially account for distinct disease outcomes among various coronavirus infections,” said Vineet Menachery, assistant professor at UTMB, who collaborated on the study. “Future studies are needed to further evaluate the current findings in the context complete virus in infection animal models.”

“This is another example of collaborative team science at UTMB,” said Dr. Ben Raimer, president ad interim of UTMB. “The collective effort from multidisciplinary teams is essential to deliver this exciting study. UTMB will continue pursuing team science to translate the knowledge for development of new diagnosis, vaccine, and therapeutics.”

MJH footer logo with red letters

Medical Journal – Houston is the leading source of healthcare business news. With extremely relevant content, late-breaking news and monthly exclusives from industry experts, MJH News has created a winning combination of must-read editorial that physicians and hospital executives eagerly anticipate month after month. MJH News is the resource that provides everything they need in one place, and it is a high honor that they rely upon Medical Journal – Houston to keep their practice or hospital on the cutting edge.

Archives